Reboxetine

Products Reboxetine is commercially available in tablet form (Edronax). It has been approved in some European countries since 1997 and in many countries since 2000. Structure and properties Reboxetine (C19H23NO3, Mr = 313.4 g/mol) is a morpholine derivative with two chiral centers. It exists in the drug as a mixture of the ,- and ,-enantiomers. … Reboxetine

Poisoning with lithium (lithium intoxication) | Lithium

Poisoning with lithium (lithium intoxication) As mentioned above, the plasma concentration of lithium should not exceed 1.2 mmol/l. However, this is only a guideline value, as the principle of individual compatibility applies here as well. From a concentration of 1.6 mmol/l on, however, the probability of the occurrence of symptoms of poisoning is considered quite … Poisoning with lithium (lithium intoxication) | Lithium

Lithium

Lithium is a classic drug that is still used today as the first-choice remedy for mania and as a preventive therapy for bipolar-effective disorders (mania depression). Lithium is available as: Lithium aspartate (lithium aspartate), Quilonum (lithium acetate), Hypnorex ret, Quilonum ret. Lithium Apogepha, Leukominerase (Lithium Carbonate), Lithium Aspartate, Lithium Acetate, Lithium Carbonate, Lithium. Fields of … Lithium

Dosage | Lithium

Dosage In general, lithium should be taken in the evening. For this reason, side effects are usually simply overslept. The amount that the individual patient has to take depends directly on the so-called plasma concentration, i.e. the amount of the drug in the blood. Particularly at the beginning of the therapy, regular blood samples must … Dosage | Lithium

Citalopram Effects and Side Effects

Products Citalopram is commercially available as film-coated tablets and as an infusion concentrate (Seropram, generics). It has been approved in many countries since 1990. The pure -enantiomer escitalopram is also available (Cipralex, generic). Structure and properties Citalopram (C20H21FN2O, Mr = 324.4 g/mol) is a racemate. It is present in the tablets as citalopram hydrobromide, a … Citalopram Effects and Side Effects

Fluoxetine: Drug Effects, Side Effects, Dosage and Uses

Products Fluoxetine is commercially available as tablets, dispersible tablets, and capsules (Fluctine, generics, USA: Prozac). It has been approved in many countries since 1991. Structure and properties Fluoxetine (C17H18F3NO, Mr = 309.3 g/mol) is present in the drugs as fluoxetine hydrochloride, a white crystalline powder that is sparingly soluble in water. It is a racemate … Fluoxetine: Drug Effects, Side Effects, Dosage and Uses

Amitriptyline: Tricyclic Antidepressant

Products Amitriptyline is commercially available as film-coated tablets and capsules (Saroten, limbitrol + chlordiazepoxide). It has been approved in many countries since 1961. The distribution of tryptizole was discontinued in 2012. Structure and properties Amitriptyline (C20H23N, Mr = 277.4 g/mol) is present in drugs as amitriptyline hydrochloride, a white powder or colorless crystals that are … Amitriptyline: Tricyclic Antidepressant

Doxepin: Drug Effects, Side Effects, Dosage and Uses

Products Doxepin is commercially available in many countries in capsule form (Sinquan) and has been approved since 1968. Structure and properties Doxepin (C19H21NO, Mr = 279.4 g/mol) is present in drugs as doxepin hydrochloride, a white crystalline powder that is readily soluble in water. It is a dibenzoxepin derivative. Effects Doxepin (ATC N06AA12) has antidepressant, … Doxepin: Drug Effects, Side Effects, Dosage and Uses

Moclobemide

Products Moclobemide is commercially available in the form of film-coated tablets (Aurorix, generics). It has been approved in many countries since 1990. Structure and properties Moclobemide (C13H17ClN2O2, Mr = 268.74 g/mol) is a morpholine and chlorinated benzamide derivative. It exists as a white to yellowish white or reddish powder and is sparingly soluble in water. … Moclobemide

Vortioxetine

Products Vortioxetine is commercially available as film-coated tablets and as an oral solution (drops). It was approved in the United States and the EU in 2013 and in many countries in 2016 (Brintellix, United States: Trintellix). Structure and properties Vortioxetine (C18H22N2S, Mr = 298.4 g/mol) is a piperazine derivative. It is present in the film-coated … Vortioxetine